Dr. Olga   A. Tarasova
My Social Links

Dr. Olga A. Tarasova

Research Scientist
Institute of Biomedical Chemistry, Russia


Highest Degree
Ph.D. in Bioinformatics from Institute of Biomedical Chemistry, Russia

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Chemoinformatics
62%
Molecular Docking
90%
Computational Chemistry
75%
Bioinformatics
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Tarasova, O., D. Filimonov and V. Poroikov, 2017. PASS-based approach to predict HIV-1 reverse transcriptase resistance. J. Bioinform. Comput. Biol., Vol. 15, No. 2. 10.1142/S0219720016500402.
    CrossRef  |  PubMed  |  Direct Link  |  
  2. Tarasova, O., A. Rudik, A. Dmitriev, A. Lagunin, D. Filimonov and V. Poroikov, 2017. QNA-Based Prediction of Sites of Metabolism. Мolecules., Vol. 22, No. 12. 10.3390/molecules22122123.
    CrossRef  |  PubMed  |  Direct Link  |  
  3. Guasch, L., A. Zakharov, O. Tarasova, V. Poroikov, C. Liao and M. Nicklaus, 2016. Novel HIV-1 Integrase Inhibitor Development by Virtual Screening Based on QSAR Models. Curr. Top. Med. Chem., 16: 441-448.
    CrossRef  |  Direct Link  |  
  4. Tarasova, O., A. Urusova, D. Filimonov, M. Nicklaus, A. Zakharov and V. Poroikov, 2015. QSAR Modeling Using Large-Scale Databases: Case Study for HIV-1 Reverse Transcriptase Inhibitors. J. Chem. Inf. Model., 55: 1388-1399.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Anusevicius, K., V. Mickevicius, M. Stasevych, V. Zvarych, and O. Komarovska- Porokhnyavets et al., 2015. Synthesis and chemoinformatics analysis of N-aryl- β -alanine derivatives. Res. Chem. Intermed., 41: 7517-7540.
    CrossRef  |  Direct Link  |  
  6. Lagunin, A., D. Filimonov, T. Gloriozova, O. Tarasova and A. Zakharov et al., 2013. Virtual screening for potential substances for the prophylaxis of HIV infection in libraries of commercially available organic compounds. Pharm. Chem. J., 47: 343-360.
    CrossRef  |  Direct Link  |  
  7. Filz, O., A. Lagunin, D. Filimonov and V. Poroikov, 2012. In silico fragment-based drug design using a PASS approach. SAR QSAR Environ. Res., 23: 279-296.
    CrossRef  |  PubMed  |  Direct Link  |  
  8. Filz, O. and V.V. Poroikov, 2012. Fragment-based lead design. Usp. Khim., 81: 158-174.
    CrossRef  |  
  9. Eleftheriou, P., A. Geronikaki, D. Hadjipavlou-Litina, P. Vicini and O. Filz et al., 2012. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. Eur. J. Med. Chem., 47: 111-124.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Filz, O., A. Lagunin, D. Filimonov and V. Poroikov, 2008. Computer-aided prediction of QT-prolongation. SAR QSAR Environ. Res., 19: 81-90.
    CrossRef  |  PubMed  |  Direct Link  |